COMMUNIQUÉS West-GlobeNewswire
-
Waylo Ahead Launches Initiative for Young Drivers Beyond the Test
12/10/2026 -
Baylor Genetics to Showcase How Genome Sequencing is Advancing Pediatric Care at the 2026 Child Neurology Society Annual Meeting
12/10/2026 -
Ozari Health Expands Nationwide GLP-1 Telehealth Platform With Two Plans for Compounded Semaglutide and Tirzepatide Starting at $86 Per Month
12/10/2026 -
Aro Biotherapeutics Reports Therapeutic Potential of Centyrin – IFIH1 siRNA Conjugate for the Treatment of Type 1 Diabetes
12/10/2026 -
IM8 Named Official Nutrition Partner of the NBA in Australia and Southeast Asia
12/10/2026 -
Ardelyx Presents Real-World Data at ACG 2026 Showing Reduced Healthcare Resource Utilization Following IBSRELA® Initiation in Adults with IBS-C
12/10/2026 -
STERIS Expands Healthcare Consumables Offering with Definitive Agreement to Acquire Xodus Medical, a Specialty Surgical Products Business Focused on Patient and OR Staff Safety
12/10/2026 -
Phathom Pharmaceuticals Highlights New Cost-Effectiveness Data and Growing Clinical Interest in VOQUEZNA® (vonoprazan) at ACG 2026
12/10/2026 -
Stryker and CMR Surgical announce strategic alliance to advance robotic-assisted surgery
12/10/2026 -
Humacyte Announces Phase 3 V012 Trial Results for ATEV in Women Requiring Hemodialysis Access Accepted for a Late-Breaking Session Presentation at ASN Kidney Week 2026
12/10/2026 -
iMDx to Participate in Virtual U.S. Bancorp I BTIG Kidney Health Forum with KOL Discussion and Investor Meetings
12/10/2026 -
Sutro Biopharma Announces Participation at the 17th Annual World ADC Conference
12/10/2026 -
Odyssey Therapeutics to Present Design of Phase 2a Study Evaluating OD-001 in Combination with Vedolizumab at ACG 2026
12/10/2026 -
Clearmind: Charging Robotics Launches Next-Generation Automated EV-Charging Technology for Robotaxis and Autonomous Fleets
12/10/2026 -
Palvella Therapeutics Announces Three Poster Presentations Highlighting New Data in Microcystic Lymphatic Malformations and DSAP at Fall Clinical Dermatology 2026
12/10/2026 -
CervoMed Presents Initial Results of Phase 2a Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Showing Positive Effects on a Key Neurodegeneration Biomarker in Late-Breaking Oral Session at ISFTD 2026
12/10/2026 -
NervGen Announces First Participant Dosed in RESTORE, a Phase 3 Registrational Study Evaluating NVG-291 in Chronic Spinal Cord Injury
12/10/2026 -
Kraig Biocraft Laboratories Files for Expanded Investment License to Fuel Spider Silk Production Growth
12/10/2026 -
How Specialty Retailers Keep Brand Voice When Outsourcing Customer Service
12/10/2026
Pages